Robert Lazar
Gastroenterology · Commack, NYNPI 1730164179
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,495 of the $9,071 with a category attached, or 60.6%. 22 manufacturers reported payments, led by Pharming Healthcare, Inc. at 43.1% of the total. Reporting peaked in 2019 at $5,670 and has fallen 92.0% since, to $451 in 2023.
Across 293 payments — averaging $30.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharming Healthcare, Inc.$4K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- AbbVie$882
- Ferring Pharmaceuticals Inc.$491
- Takeda Pharmaceuticals U.S.A., Inc.$366
- QOL Medical, LLC$347
- plus $2K from 16 others
What the payments were for
- Speaking & faculty fees$3,37237%
- Travel & lodging$2052%
- Food & beverage$5,49561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pharming Healthcare, Inc. | 4 | $3,913 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 55 | $1,022 |
| AbbVie(2 entities) | 55 | $882 |
| Ferring Pharmaceuticals Inc. | 26 | $491 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $366 |
| QOL Medical, LLC | 29 | $347 |
| Nestle Healthcare Nutrition Inc. | 15 | $325 |
| E.r. Squibb & Sons, L.L.C. | 2 | $262 |
| Braintree Laboratories, Inc. | 10 | $249 |
| Ironwood Pharmaceuticals, Inc | 13 | $218 |
| Johnson & Johnson | 11 | $209 |
| Bristol Myers Squibb | 12 | $207 |
| Daiichi Sankyo Inc. | 9 | $169 |
| Merck | 8 | $114 |
| Intercept Pharmaceuticals, Inc. | 4 | $74 |
| Ardelyx, Inc. | 4 | $69 |
| Redhill Biopharma Inc. | 3 | $42 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Vivus LLC | 1 | $21 |
| UCB, Inc. | 1 | $20 |
| Shire North American Group Inc | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,071 in reported general payments places this provider in the 75th percentile of 1,682 gastroenterology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 15 | $142 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Commack
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Maya SrivastavaWilliamsville$1.8M
- Melissa PalmerPlainview$1M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
- Bruce SandsNew York$810K
- Jean Frederick ColombelNew York$786K
- Seth GrossNew York$624K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.